Targeting p53 for enhanced radio- and chemo-sensitivity
- 4 March 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Apoptosis
- Vol. 14 (4), 597-606
- https://doi.org/10.1007/s10495-009-0330-1
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2Leukemia, 2008
- PACT is a negative regulator of p53 and essential for cell growth and embryonic developmentProceedings of the National Academy of Sciences of the United States of America, 2007
- Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenograftsProceedings of the National Academy of Sciences of the United States of America, 2006
- Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 InteractionJournal of Medicinal Chemistry, 2006
- Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumorsNature Medicine, 2004
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- Targeting the p53–MDM2 interaction to treat cancerBritish Journal of Cancer, 2004
- The ubiquitin ligase COP1 is a critical negative regulator of p53Nature, 2004
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003
- Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compoundNature Medicine, 2002